Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul 20;2005(3):CD003873.
doi: 10.1002/14651858.CD003873.pub2.

Interventions for growth failure in childhood Crohn's disease

E A Newby, A Sawczenko, A G Thomas, D Wilson

Interventions for growth failure in childhood Crohn's disease

E A Newby et al. Cochrane Database Syst Rev. .

Abstract

Background: Crohn's disease in childhood is a chronic relapsing condition. Fifteen to forty per cent of children with Crohn's disease have growth retardation (Griffiths 1993a). Some treatment modalities including corticosteroids have been implicated in growth failure but it is thought mainly to be secondary to uncontrolled disease activity (Motil 1993; Markowitz 1993). Growth is fundamental to the practice of pediatrics, so by taking growth as the primary outcome measure we address issues important to both patients, their families and pediatricians.

Objectives: To evaluate the effectiveness of the different modalities available for the treatment of childhood Crohn's disease with regard to the reversal of growth failure and the promotion of normal growth.

Search strategy: Searches were made of the following databases using the Collaborative Review Group Search Strategy: EMBASE (1984-2004), MEDLINE (1966-2004), The Cochrane Central Register of Controlled Trials, The Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group Specialized Trials Register and the Science Citation Index. Abstracts from the major gastrointestinal research meetings and references from published articles were also reviewed.

Selection criteria: Randomized controlled trials pertaining to children less than 18 years of age with Crohn's disease were selected. Those with growth as an outcome measure were included in the review.

Data collection and analysis: Data extraction and assessment of the methodological quality of each trial was independently reviewed by two reviewers. Only one good quality randomized controlled trial was included in the review and therefore no statistical analysis was possible.

Main results: Three randomized controlled trials were identified. One was of good methodological quality (Markowitz 2000). This study looked at the use of 6-mercaptopurine (6-MP) as a steroid sparing agent. No difference in linear growth was observed between the intervention and placebo groups, although the total steroid dose received over the 18 month follow up period was reduced in the group receiving 6-MP. The two remaining randomized controlled trials (Sanderson 1987; Thomas 1993a) consider the use of enteral feeding versus corticosteroids for induction of remission, with height velocity standard deviation score at 6 months as an outcome measure. Although of less rigorous methodological quality, the results of these studies are discussed in detail in the review. In both studies height velocity standard deviation scores were significantly increased in the enteral feeding group compared with the corticosteroid group.

Authors' conclusions: In addition to these randomized controlled trials, a body of lower quality evidence does exist relevant to two other important interventions; the use of supplemental enteral nutrition (Morin 1980; Belli 1988; Israel 1995) and the judicious use of surgical interventions in pre-pubertal children with refractory disease (Alperstein 1985; Lipson 1990; McLain 1990). Newer treatments, such as infliximab, are now becoming more widely used and may offer advantages in promoting growth. These effects are as yet unstudied. This review highlights the need for large, multi centre studies of the different treatment options in paediatric Crohn's disease and the importance of standardised measurements of growth, such as height velocity standard deviation scores and height standard deviation scores as outcome measures.

PubMed Disclaimer

Conflict of interest statement

AG Thomas is the author of a manuscript that was included in this review.

Figures

1.1
1.1. Analysis
Comparison 1: 6‐mercaptopurine versus placebo, Outcome 1: Linear growth
2.1
2.1. Analysis
Comparison 2: Elemental feed versus prednisolone, Outcome 1: Height velocity standard deviation scores
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD003873

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Markowitz 2000 {published data only}
    1. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119(4):895-902. - PubMed
Sanderson 1987 {published data only}
    1. Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987;62(2):123-7. - PMC - PubMed
Thomas 1993a {published data only}
    1. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 1993;17(1):75-81. - PubMed

References to studies excluded from this review

Akobeng 2000 {published data only}
    1. Akobeng A, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000;30(1):78-84. - PubMed
Akobeng 2002 {published data only}
    1. Akobeng AK, Clayton PE, Miller V, Hall CM, Thomas AG. Low serum concentrations of insulin-like growth factor-I in children with active Crohn's disease: effect of enteral nutritional support and glutamine supplementation. Scand J Gastroenterol 2002;37(12):1422-7. - PubMed
Alperstein 1985 {published data only}
    1. Alperstein G, Daum F, Fisher SE, Aiges H, Markowitz J, Becker J, et al. Linear growth following surgery in children and adolescents with Crohn's disease: relationship to pubertal status. J Pediatr Surg 1985;20(2):129-33. - PubMed
Baldassano 2003 {published data only}
    1. Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, et al. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am J Gastroenterol 2003;98(4):833-8. - PubMed
Belli 1988 {published data only}
    1. Belli DC, Seidman E, Bouthillier L, Weber AM, Roy CC, Pletincx M, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988;94(3):603-10. - PubMed
Campieri 1997 {published data only}
    1. Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Gut 1997;41(2):209-14. - PMC - PubMed
Cezard 2003 {published data only}
    1. Cezard JP, Nouaili N, Talbotec C, Hugot JP, Gobert JG, Schmitz J, et al. A prospective study of the efficacy and tolerance of a chimeric antibody to tumour necrosis factors (remicade) in severe pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 2003;36(5):632-6. - PubMed
Davies 1990 {published data only}
    1. Davies G, Evans CM, Shand WS, Walker-Smith JA. Surgery for Crohn's disease in childhood: influence of disease and operative procedure on outcome. Br J Surg 1990;77(8):891-4. - PubMed
Escher 2004 {published data only}
    1. Escher JC, European Collaborative Research Group on Budesonide in Paediatric IBD. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial. Eur J Gastroenterol Hepatol 2004;16(1):47-54. - PubMed
Gassull 2002 {published data only}
    1. Gassull MA, Fernandez-Banares F, Cabre E, Papo M, Giaffer MH, Sanchez-Lombrana JL, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002;51(2):164-8. - PMC - PubMed
Gaya 1999 {published data only}
    1. Gaya DR. Crohn's disease in childhood: the case for enteral nutrition. Scott Med J 1999;44(3):68-70. - PubMed
Gorard 1993 {published data only}
    1. Gorard DA, Hunt JB, Payne-James JJ, Palmer KR, Rees RG, Clark ML, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993;34(9):1198-202. - PMC - PubMed
Griffiths 1993b {published data only}
    1. Griffths A, Koletzko S, Sylvester F, Marcon M, Sherman P. Slow-release 5-aminosalicylic acid therapy in children with small intestinal Crohn's disease. J Pediatr Gastroenterol Nutr 1993;17(2):186-92. - PubMed
Israel 1995 {published data only}
    1. Israel DM, Hassall E. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn's disease. Am J Gastroenterol 1995;90(7):1084-8. - PubMed
Khoshoo 1996 {published data only}
    1. Khoshoo V, Reifen R, Neuman MG, Griffiths A, Pencharz PB. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease. JPEN J Parenter Enteral Nutr 1996;20(6):401-5. - PubMed
Kugathasan 2000 {published data only}
    1. Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am J Gastroenterol 2000;95(11):3189-94. - PubMed
Kundhal 2001 {published data only}
    1. Kundhal P, Zachos M, Holmes JL, Griffiths AM. Controlled ileal release budesonide in pediatric Crohn disease: efficacy and effect on growth. J Pediatr Gastroenterol Nutr 2001;33(1):75-80. - PubMed
Kundhal 2003 {published data only}
    1. Kundal PS, Critch JN, Zachos M, Otley AR, Stephens D, Griffiths AM. Pediatric Crohn Disease Activity Index: responsive to short-term change. J Pediatr Gastroenterol Nutr 2003;36(1):83-9. - PubMed
Lake 1985 {published data only}
    1. Lake AM, Kim S, Mathis RK, Walker WA. Influence of preoperative parenteral alimentation on postoperative growth in adolescent Crohn's disease. J Pediatr Gastroenterol Nutr 1985;4(2):182-6. - PubMed
Layden 1976 {published data only}
    1. Layden T, Rosenberg F, Nemchausky G, Elson C, Rosenberg I. Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation. Gastroenterology 1976;70(6):1017-21. - PubMed
Levine 2003 {published data only}
    1. Levine A, Weizman Z, Broide E, Shamir R, Shaoul R, Pacht A, et al. A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2003;36(2):248-52. - PubMed
Lipson 1990 {published data only}
    1. Lipson AB, Savage MO, Davies PS, Bassett K, Shand WS, Walker-Smith JA. Acceleration of linear growth following intestinal resection for Crohn disease. Eur J Pediatr 1990;149(10):687-90. - PubMed
Ludvigsson 2004 {published data only}
    1. Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B. Elemental verses polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. Acta Paediatr 2004;93(3):327-35. - PubMed
Mahdi 1996 {published data only}
    1. Mahdi G, Israel DM, Hassall E. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children. Am J Gastroenterol 1996;91(7):1355-9. - PubMed
McLain 1990 {published data only}
    1. McLain BI, Davidson PM, Stokes KB, Beasley SW. Growth after gut resection for Crohn's disease. Arch Dis Child 1990;65(7):760-2. - PMC - PubMed
Morin 1980 {published data only}
    1. Morin CL, Roulet M, Roy CC, Weber A. Continuous elemental enteral alimentation in children with Crohn's disease and growth failure. Gastroenterology 1980;79(6):1205-10. - PubMed
Motil 1993 {published data only}
    1. Motil KJ, Grand RJ, Davis-Kraft L, Ferlic LL, Smith EO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105(3):681-91. - PubMed
Nicholls 1994 {published data only}
    1. Nicholls S, Domizio P, Williams CB, Dawnay A, Braegger CP, MacDonald TT, et al. Cyclosporin as initial treatment for Crohn's disease. Arch Dis Child 1994;71(3):243-7. - PMC - PubMed
Papadopoulou 1995 {published data only}
    1. Papadopoulou A, Rawashdeh MO, Brown GA, McNeish AS, Booth IW. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Pediatr 1995;84(1):79-83. - PubMed
Polk 1992 {published data only}
    1. Polk DB, Hattner JA, Kerner JA Jr. Improved growth and disease activity after intermittent administration of a defined formula diet in children with Crohn's disease. JPEN J Parenter Enteral Nutr 1992;16(6):499-504. - PubMed
Royall 1995 {published data only}
    1. Royall D, Greenberg GR, Allard JP, Baker JP, Jeejeebhoy KN. Total enteral nutrition support improves body composition of patients with active Crohn's disease. JPEN J Parenter Enteral Nutr 1995;19(2):95-9. - PubMed
Ruuska 1994 {published data only}
    1. Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994;19(2):175-80. - PubMed
Seidman 1996 {published data only}
    1. Seidman E, Jones A, Issenman R, Griffiths A. Relapse prevention/growth enhancement in pediatric Crohn's disease: a multi-centre randomized controlled trial of intermittent enteral nutrition versus alternate day steroids. J Pediatr Gastroenterol Nutr 1996;23(3):344.
Sentongo 2000 {published data only}
    1. Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31(1):33-40. - PubMed
Stober 1983 {published data only}
    1. Stober B, Nutzenadel W, Ullrich F. Basic diet in Crohn's disease [Elementardiat bei Morbus Crohn]. Monatsschr Kinderheilkd 1983;131(10):721-4. - PubMed
Strobel 1979 {published data only}
    1. Strobel CT, Byrne WJ, Ament ME. Home parenteral nutrition in children with Crohn's disease: an effective management alternative. Gastrenterology 1979;77(2):272-9. - PubMed
Thomas 1993b {published data only}
    1. Thomas AG, Holly JM, Taylor F, Miller V. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993;34(7):944-7. - PMC - PubMed
Wilschanski 1996 {published data only}
    1. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996;38(4):543-8. - PMC - PubMed
Zoli 1997 {published data only}
    1. Zoli G, Care M, Parazza M, Spano C, Biagi PL, Bernardi M, et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease. Aliment Pharmacol Ther 1997;11(4):735-40. - PubMed

Additional references

Akobeng 1999
    1. Akobeng AK, Suresh-Babu MV, Firth D, Miller V, Mir P, Thomas AG. Quality of life in children with Crohn's disease: a pilot study. J Pediatr Gastroenterol Nutr 1999;28(4):S37-9. - PubMed
Akobeng 2005
    1. Akobeng Ak, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No: CD003715. Art. No: CD003715. [DOI: Art. No.: CD003715. DOI: 10.1002/14651858.CD003715.pub2] - PubMed
Ballinger 2000
    1. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000;46(5):694-700. - PMC - PubMed
Beattie 1998
    1. Beattie RM, Camacho-Hubner C, Wacharsindhu S, Cotterill AM, Walker-Smith JA, Savage MO. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol (Oxf) 1998;49(4):483-9. - PubMed
Breese 1994
    1. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, et al. Tumour necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106(6):1455-66. - PubMed
Buller 2000
    1. Buller HA. Growth in children with inflammatory bowel disease. Research and Clinical Forums 2000;22(2):139-44.
Chafai 1995
    1. Chafai S, Martin D, Goulet O, Mougenot JF, Ricour C, Schmitz J. Semi-elemental diet and corticosteroids in the treatment of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1995;220:465.
Clarke 2003
    1. Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.2 [updated March 2003]. In: The Cochrane Library, Issue 4. Oxford: Update software, 2003.
Cosgrove 1997
    1. Cosgrove M, Jenkins HR. Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease. Arch Dis Child 1997;76(2):141-3. - PMC - PubMed
De Benedetti 1997
    1. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99(4):643-50. - PMC - PubMed
Evans 1991
    1. Evans CM, Kirk JM, Savage MO, Walker Smith JA. Growth after gut resection for Crohn's disease. Arch Dis Child 1991;66(3):370. - PMC - PubMed
Ferguson 1994
    1. Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ 1994;308(6939):1259-63. - PMC - PubMed
Griffiths 1991
    1. Griffiths AM, Wesson DE, Shandling B, Corey M, Sherman PM. Factors influencing the postoperative recurrence of Crohn's disease in childhood. Gut 1991;32(5):491-5. - PMC - PubMed
Griffiths 1993a
    1. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut 1993;34(7):939-43. - PMC - PubMed
Heuschkel 2000
    1. Heuschkel R, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000;31(1):8-15. - PubMed
Hildebrand 1994
    1. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994;18(2):165-73. - PubMed
Hyams 1988
    1. Hyams JS, Carey DE. Corticosteroids and growth. J Pediatr 1988;113(2):249-54. - PubMed
Hyams 1991
    1. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12(4):439-47. - PubMed
Hyams 2000
    1. Hyams JS, Markowitz J, Wyllie R. Use of infliximab in the treatment of Crohn's disease in children and adolescents. J Pediatr 2000;137(2):192-6. - PubMed
Jadad 1998
    1. Jadad AR. Randomised controlled trials: a user's guide. London: BMJ Books, 1998.
Keller 1992
    1. Keller KM, Wirth S. Parenteral nutrition in treatment of short stature in adolescents with Crohn disease [Parenterale Ernahrung in der Behandlung des Minderwuchses bei Adoleszenten mit Morbus Crohn]. Klin Padiatr 1992;204(6):411-6. - PubMed
Kirschner 1986
    1. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986;91(4):830-6. - PubMed
Markowitz 1993
    1. Markowitz J, Grancher K, Rosa J, Aiges H, Daum F. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;16(4):373-80. - PubMed
Murch 1991
    1. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 1991;32(8):913-7. - PMC - PubMed
Pearson 1998
    1. Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 1998, Issue 4. Art. No: CD000067. Art. No: CD000067. [DOI: Art. No.: CD000067. DOI: 10.1002/14651858.CD000067]
Seidman 1991
    1. Seidman EG, Lohoues MJ, Turgeon L, Bouthillier L, Morin CL. Elemental diet versus prednisone as initial therapy in Crohn's disease: early and long term results. Gastroenterology 1991;100(5 Part 2):A250.
Seidman 1993
    1. Seidman E, Griffiths AM, Jones A, Issenman R. Semi-elemental (S-E) diet vs prednisone in pediatric Crohn's disease. Gastroenterology 1993;104(4 Part 2):A778.
Slonim 2000
    1. Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinlay MJ. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000;342(22):1633-7. - PubMed
Stephens 2003
    1. Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol 2003;98(1):104-11. - PubMed
Sutherland 2006
    1. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No: CD000544. Art. No: CD000544. [DOI: Art. No.: CD000544. DOI: 10.1002/14651858.CD000544.pub2] - PubMed
Walker‐Smith 1996
    1. Walker-Smith JA. Management of growth failure in Crohn's disease. Arch Dis Child 1996;75(4):351-4. - PMC - PubMed
Zachos 2007
    1. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No: CD000542. Art. No: CD000542. [DOI: Art. No.: CD000542. DOI: 10.1002/14651858.CD000542.pub2] - PubMed

Publication types

MeSH terms